EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Rubius Therapeutics Inc Com (RUBY) stock?

You can purchase shares of Rubius Therapeutics Inc Com (OTC: RUBY) through any online brokerage.

View our list of the best stock brokerages.

Who are Rubius Therapeutics Inc Com's (RUBY) competitors?

There are no as such competitors for Rubius Therapeutics Inc Com.

What is the target price for Rubius Therapeutics Inc Com (RUBY) stock?

The latest price target for Rubius Therapeutics Inc Com (OTC: RUBY) was reported by Guggenheim on Tuesday, September 13, 2022. The analyst firm set a price target for 0.00 expecting RUBY to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.

Current Stock Price for Rubius Therapeutics Inc Com (RUBY)?

The stock price for Rubius Therapeutics Inc Com (OTC: RUBY) is $0.057 last updated December 29, 2023 at 3:49 PM EST.

Does Rubius Therapeutics Inc Com (RUBY) pay a dividend?

There are no upcoming dividends for Rubius Therapeutics Inc Com.

When is Rubius Therapeutics Inc Com (OTC:RUBY) reporting earnings?

Rubius Therapeutics Inc Com’s Q4 earnings are confirmed for Monday, February 27, 2023.

Is Rubius Therapeutics Inc Com (RUBY) going to split?

There is no upcoming split for Rubius Therapeutics Inc Com.

What sector and industry does Rubius Therapeutics Inc Com (RUBY) operate in?

Rubius Therapeutics Inc Com is in the Health Care sector and Biotechnology industry. They are listed on the OTC.